Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To assess the survival benefit from an early switch approach from sunitinib or pazopanib to nivolumab (anti-angiogenic to immunotherapy switch)
Inclusion criteria
- advanced or metastatic renal cell carcinoma (RCC),fortgeschrittenes oder metastasiertes Nierenzellkarzinom